Shares in Lannett plunged 55% after the generic-pharmaceuticals maker said a distribution pact with a key supplier won’t be renewed next year and that it would expand restructuring efforts to reduce costs.
from WSJ.com: US Business https://ift.tt/2N2IR6b
via IFTTT
No comments:
Post a Comment